You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

lee011

Showing 1 - 22 of 22
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Hormone Receptor Positive, HER2-negative, Advanced Breast Cancer Trial in Hong Kong, Japan, Singapore (LEE011, Letrozole,

Completed
  • Hormone Receptor Positive, HER2-negative, Advanced Breast Cancer
  • LEE011
  • +4 more
  • Hong Kong, Hong Kong
  • +14 more
Oct 25, 2022

Neuroendocrine Tumors Trial in Boston, New York, Houston (LEE011, everolimus)

Active, not recruiting
  • Neuroendocrine Tumors
  • Boston, Massachusetts
  • +4 more
Feb 22, 2022

Myelofibrosis Trial in Worldwide (PIM447, Ruxolitinib, LEE011)

Completed
  • Myelofibrosis
  • VIC, Melbourne, Australia
  • +8 more
Feb 7, 2022

Breast Cancer Trial in Worldwide (LEE011, Letrozole, BYL719)

Active, not recruiting
  • Breast Cancer
  • LEE011
  • +2 more
  • San Diego, California
  • +23 more
Feb 17, 2022

Hepatocellular Carcinoma Trial in Dallas (LEE011, Chemoembolization)

Terminated
Has Results
  • Hepatocellular Carcinoma
  • LEE011
  • Chemoembolization
  • Dallas, Texas
    UT Southwestern Medical Center
Jan 28, 2021

Advanced Solid Tumors Trial in Kashiwa, Chuo-ku (LEE011)

Completed
  • Advanced Solid Tumors
  • LEE011
  • Kashiwa, Chiba, Japan
  • +1 more
Dec 16, 2020

Normal Hepatic Function, Impaired Hepatic Function Trial in Anaheim, Coral Gables, Orlando (LEE011)

Completed
  • Normal Hepatic Function
  • Impaired Hepatic Function
  • LEE011
  • Anaheim, California
  • +2 more
Dec 16, 2020

Normal Renal Function, Impaired Renal Function Trial in Worldwide (LEE011)

Completed
  • Normal Renal Function
  • Impaired Renal Function
  • LEE011
  • Minneapolis, Minnesota
  • +3 more
Dec 16, 2020

Advanced Solid Tumor, Lymphomas Trial in France, Netherlands, United States (LEE011)

Completed
  • Advanced Solid Tumor
  • Lymphomas
  • LEE011
  • Boston, Massachusetts
  • +6 more
Dec 16, 2020

Liposarcoma Trial in Worldwide (HDM201, LEE011)

Completed
  • Liposarcoma
  • Toronto, Ontario, Canada
  • +8 more
Dec 6, 2020

Teratoma Trial in Worldwide (LEE011, LEE011 Placebo)

Completed
Has Results
  • Teratoma
  • LEE011
  • LEE011 Placebo
  • Los Angeles, California
  • +6 more
Oct 1, 2020

Breast Cancer Trial in Worldwide (LEE011, BYL719, fulvestrant)

Completed
  • Breast Cancer
  • LEE011
  • +3 more
  • Birmingham, Alabama
  • +10 more
Dec 16, 2020

Advanced or Metastatic Breast Cancer Trial in Spain, United States (LEE011, Buparlisib, Letrozole)

Completed
  • Advanced or Metastatic Breast Cancer
  • LEE011
  • +2 more
  • Los Angeles, California
  • +5 more
Dec 16, 2020

Solid Tumors Harboring a BRAF V600 Mutation Trial in Worldwide (LGX818, MEK162, LEE011)

Active, not recruiting
  • Solid Tumors Harboring a BRAF V600 Mutation
  • Tampa, Florida
  • +22 more
Mar 16, 2022

Locally Advanced or Metastatic NRAS Mutant Melanoma Trial in Worldwide (LEE011, MEK162)

Completed
Has Results
  • Locally Advanced or Metastatic NRAS Mutant Melanoma
  • San Francisco, California
  • +16 more
Nov 23, 2020

Melanoma Trial in Worldwide (LGX818, MEK162, LEE011)

Active, not recruiting
  • Melanoma
  • Los Angeles, California
  • +31 more
Jun 11, 2021

Squamous Cell Carcinoma of the Head and Neck Trial in Belgium (LEE011)

Terminated
  • Squamous Cell Carcinoma of the Head and Neck
  • LEE011
  • Charleroi, Hainaut, Belgium
  • +4 more
Jan 7, 2020

Advanced, Metastatic Breast Cancer Trial in Worldwide (LEE011, Letrozole, LEE011 Placebo)

Active, not recruiting
Has Results
  • Advanced, Metastatic Breast Cancer
  • LEE011
  • +2 more
  • Chandler, Arizona
  • +222 more
Dec 3, 2021

Malignant Rhabdoid Tumors (MRT), Neuroblastoma Trial in Worldwide (LEE011)

Terminated
Has Results
  • Malignant Rhabdoid Tumors (MRT)
  • Neuroblastoma
  • LEE011
  • San Francisco, California
  • +12 more
Nov 13, 2019

Metastatic Pancreatic Adenocarcinoma Trial in Washington (LEE011, Everolimus)

Unknown status
  • Metastatic Pancreatic Adenocarcinoma
  • Washington, District of Columbia
    Lombardi Comprehensive Cancer Center
May 20, 2019

Tumors With CDK4/6 Pathway Activation Trial in United States (LEE011)

Completed
Has Results
  • Tumors With CDK4/6 Pathway Activation
  • LEE011
  • Birmingham, Alabama
  • +60 more
Jul 16, 2019

Locally Advanced Metastatic BRAF Mutant Melanoma Trial in Worldwide (LEE011, LGX818)

Terminated
Has Results
  • Locally Advanced Metastatic BRAF Mutant Melanoma
  • Aurora, Colorado
  • +8 more
Jul 27, 2016